Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Revolution Medicines (RVMD) Shares Outstanding (2018 - 2025)

Revolution Medicines has reported Shares Outstanding over the past 8 years, most recently at $197.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $197.0 million for Q4 2025, up 5.97% from a year ago — trailing twelve months through Dec 2025 was $197.0 million (up 5.97% YoY), and the annual figure for FY2025 was $197.0 million, up 5.97%.
  • Shares Outstanding for Q4 2025 was $197.0 million at Revolution Medicines, up from $189.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding for RVMD hit a ceiling of $197.0 million in Q4 2025 and a floor of $2.0 million in Q1 2023.
  • Median Shares Outstanding over the past 5 years was $109.3 million (2023), compared with a mean of $122.6 million.
  • Biggest five-year swings in Shares Outstanding: tumbled 97.24% in 2023 and later surged 7962.42% in 2024.
  • Revolution Medicines' Shares Outstanding stood at $74.1 million in 2021, then grew by 21.94% to $90.4 million in 2022, then surged by 82.14% to $164.7 million in 2023, then increased by 12.89% to $185.9 million in 2024, then rose by 5.97% to $197.0 million in 2025.
  • The last three reported values for Shares Outstanding were $197.0 million (Q4 2025), $189.7 million (Q3 2025), and $186.9 million (Q2 2025) per Business Quant data.